Mesenchymal Stem Cells Mitigate Cirrhosis through BMP7

Background/Aims: Transplantation of mesenchymal stem cells (MSCs) has therapeutic effects on various diseases, while its effect on developing cirrhosis as well as the underlying mechanism remained largely unknown. Methods: Twenty C57BL/6 mice were randomly separated into 2 groups of ten each. One group received transplantation of MSCs, while the other group received saline as control. The mice then received intraperitoneal injection of carbon tetrachloride (CCl4) twice per week for 8 weeks to develop cirrhosis. After another 4 weeks, the levels of cirrhosis in these mice were evaluated by liver fibrosis area, portal pressure, sodium balance and excretion. Transcripts of transforming growth factor β 1 (TGFβ1) and bone morphogenic protein 7 (BMP7) in the mouse livers were quantified by RT-qPCR. BMP7-depleted MSCs were prepared and applied in this model, and compared to MSCs. Results: Liver fibrosis, portal hypertension and sodium retention that were developed by CCl4, were all significantly alleviated by MSCs transplantation, which decreased TGFβ1 levels and increased BMP7 levels in the injured liver. MSCs were found to express extremely high levels of BMP7. Knockdown of BMP7 in MSCs completely abolished the protective effect of MSCs against CCl4-induced cirrhosis. Conclusions: MSCs mitigate cirrhosis through their production of BMP7 against the fibrogenic effect of TGFβ1 in the injured liver.

• Publication year

  2015

• Venue

  Cellular Physiology and Biochemistry

• Publication date

  2015-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000369708PMID 25613158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Animal Models of Primary Biliary Cirrhosis

  2015cited by this paper
• Macrophages Regulate Renal Fibrosis Through Modulating TGFβ Superfamily Signaling

  2014cited by this paper
• Mesenchymal Stem Cells Alleviate Experimental Asthma by Inducing Polarization of Alveolar Macrophages

  2014cited by this paper
• Renal lymph circulation blockage alters the epithelial cell phenotype and tubular integrity: role of distinct regulation of BMP7 and TGF-β/Smads signaling pathway

  2014cited by this paper
• M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7

  2014cited by this paper
• TGF-beta signaling-dependent alleviation of dextran sulfate sodium-induced colitis by mesenchymal stem cell transplantation

  2014cited by this paper
• Animal Models of Primary Biliary Cirrhosis

  2014cited by this paper
• The immunobiology and pathophysiology of primary biliary cirrhosis.

  2013cited by this paper
• Hedgehog Signaling Regulates the Repair Response in Mouse Liver Damaged by Irradiation

  2013cited by this paper
• Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice.

  2013cited by this paper
• TGFβ signalling in context

  2012cited by this paper
• Animal models of primary biliary cirrhosis: materials and methods.

  2012cited by this paper
• Approaches to the pathogenesis of primary biliary cirrhosis through animal models.

  2012cited by this paper
• Decorin–TGFβ Axis in Hepatic Fibrosis and Cirrhosis

  2012cited by this paper
• Role of TGF-β and BMP7 in the pathogenesis of oral submucous fibrosis

  2011cited by this paper
• Transforming growth factor-β and Smads.

  2011cited by this paper
• Pathological Features of New Animal Models for Primary Biliary Cirrhosis

  2011cited by this paper
• Role of TGF-beta beta and BMP7 in the pathogenesis of oral submucous fibrosis

  2011cited by this paper
• Update on primary biliary cirrhosis.

  2010cited by this paper
• Experimental evidence on the immunopathogenesis of primary biliary cirrhosis

  2010cited by this paper
• Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect

  2009cited by this paper
• Innate immunity and primary biliary cirrhosis.

  2009cited by this paper
• Animal models of primary biliary cirrhosis.

  2008cited by this paper
• Mesenchymal stem cells in health and disease

  2008cited by this paper
• BMP‐7 functions as a novel hormone to facilitate liver regeneration

  2007cited by this paper
• Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition*

  2007cited by this paper
• TGF-beta and BMP7 interactions in tumour progression and bone metastasis.

  2007cited by this paper
• TGF-β and BMP7 interactions in tumour progression and bone metastasis

  2007cited by this paper
• Bone Morphogenetic Protein 7 is Elevated in Patients with Chronic Liver Disease and Exerts Fibrogenic Effects on Human Hepatic Stellate Cells

  2007cited by this paper
• Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats

  2006cited by this paper
• Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair.

  2004cited by this paper
• BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells

  2003cited by this paper
• BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

  2003cited by this paper
• Immunopathogenesis of Primary Biliary Cirrhosis

  2002cited by this paper
• Cirrhosis--can we reverse hepatic fibrosis?

  2002cited by this paper
• Biliary cirrhosis

  1939cited by this paper

• Heterogeneous expression of BMP7, HIF-2α, Ki-67, and E-Cadherin in clear cell renal carcinoma: Prognostic implications based on tumor region.

  2025cites this paper
• Advances and clinical challenges of mesenchymal stem cell therapy

  2024cites this paper
• 4-Methylguaiacol alleviated alcoholic liver injury by increasing antioxidant capacity and enhancing autophagy through the Nrf2-Keap1 pathway

  2022cites this paper
• Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges

  2021cites this paper
• Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases.

  2019cites this paper
• Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach.

  2019cites this paper
• Improved therapeutic effects on diabetic foot by human mesenchymal stem cells expressing MALAT1 as a sponge for microRNA-205-5p

  2019cites this paper
• Environmental Benzopyrene Attenuates Stemness of Placenta-Derived Mesenchymal Stem Cells via Aryl Hydrocarbon Receptor

  2019cites this paper
• Enhancement of tendon-bone healing following rotator cuff repair using hydroxyapatite with TGFβ1

  2018cites this paper
• Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases.

  2018cites this paper
• Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis.

  2018cites this paper
• Aryl hydrocarbon receptor suppresses the osteogenesis of mesenchymal stem cells in collagen‐induced arthritic mice through the inhibition of &bgr;‐catenin

  2017cites this paper
• Up-Regulation of TGF-β Promotes Tendon-to-Bone Healing after Anterior Cruciate Ligament Reconstruction using Bone Marrow-Derived Mesenchymal Stem Cells through the TGF-β/MAPK Signaling Pathway in a New Zealand White Rabbit Model

  2017cites this paper
• Expression of antisense of microRNA-26a-5p in mesenchymal stem cells increases their therapeutic effects against cirrhosis.

  2017cites this paper
• MicroRNA-137 inhibits BMP7 to enhance the epithelial-mesenchymal transition of breast cancer cells

  2017cites this paper
• Suppression of MicroRNA-383 Enhances Therapeutic Potential of Human Bone-Marrow-Derived Mesenchymal Stem Cells in Treating Spinal Cord Injury via GDNF

  2017cites this paper
• Progress in stem cell‐based therapy for liver disease

  2017cites this paper
• Suppression of microRNA-205-5p in human mesenchymal stem cells improves their therapeutic potential in treating diabetic foot disease

  2017cites this paper
• Mesenchymal Stem Cell Therapy for Liver Cirrhosis Treatment: Mechanisms and Bioeffects

  2017cites this paper
• Suppression of MicroRNA-219-5p Activates Keratinocyte Growth Factor to Mitigate Severity of Experimental Cirrhosis

  2016cites this paper
• Bone morphogenetic proteins in inflammation, glucose homeostasis and adipose tissue energy metabolism.

  2016cites this paper
• Mesenchymal Stem Cells Alleviate LPS-Induced Acute Lung Injury in Mice by MiR-142a-5p-Controlled Pulmonary Endothelial Cell Autophagy

  2016cites this paper
• Modulation of mesenchymal stem cells with miR-375 to improve their therapeutic outcome during scar formation.

  2016cites this paper
• Mesenchymal Stem Cells with Enhanced Bcl-2 Expression Promote Liver Recovery in a Rat Model of Hepatic Cirrhosis

  2016cites this paper
• Human umbilical cord mesenchymal stem cells ameliorate experimental cirrhosis through activation of keratinocyte growth factor by suppressing microRNA-199.

  2016cites this paper
• Raf Kinase Inhibitory Protein Down-Expression Exacerbates Hepatic Fibrosis In Vivo and In Vitro

  2016cites this paper
• Mesenchymal stem cells alleviate experimental rheumatoid arthritis through microRNA-regulated IκB expression

  2016cites this paper
• Role of CTGF gene promoter methylation in the development of hepatic fibrosis.

  2016influential citation
• MiR542-3p Regulates the Epithelial-Mesenchymal Transition by Directly Targeting BMP7 in NRK52e

  2015cites this paper
• MiR-22 Suppresses BMP7 in the Development of Cirrhosis

  2015cites this paper
• The Therapeutic Promise of Mesenchymal Stem Cells for Liver Restoration.

  2015cites this paper
• Placental Growth Factor Promotes Cardiac Muscle Repair via Enhanced Neovascularization

  2015cites this paper